These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9519863)

  • 1. Flow cytometric analysis of cellular changes in mice after intradermal inoculation with a liposome-iscom adjuvanted vaccine.
    San Gil F; Turner B; Mullbacher A; Walker MJ; Djordjevic SP; Eamens GJ; Chin JC
    Scand J Immunol; 1998 Mar; 47(3):243-53. PubMed ID: 9519863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of adjuvant to adaptive immune responses in mice against Actinobacillus pleuropneumoniae.
    San Gil F; Turner B; Walker MJ; Djordjevic SP; Chin JC
    Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2595-2603. PubMed ID: 10517613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin delivery of a hybrid liposome/ISCOM vaccine implicates a role for adjuvants in rapid modulation of inflammatory cells involved in innate immunity before the enhancement of adaptive immune responses.
    Chin J; San Gil F
    Immunol Cell Biol; 1998 Jun; 76(3):245-55. PubMed ID: 9682968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses of a liposome/ISCOM vaccine adjuvant against streptococcal fibronectin binding protein 1 (Sfb1) in mice.
    McArthur J; Schulze K; Chin J; Currie BJ; Sriprakash KS; Talay SR; Chhatwal GS; Guzmán CA; Walker MJ
    Indian J Med Res; 2004 May; 119 Suppl():115-20. PubMed ID: 15232175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulating systemic and mucosal immune responses with skin-deliverable adjuvants.
    Chin J; San Gil F; Novak M; Eamens G; Djordjevic S; Simecka J; Duncan J; Mullbacher A
    J Biotechnol; 1996 Jan; 44(1-3):13-9. PubMed ID: 8717381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine.
    Polakos NK; Drane D; Cox J; Ng P; Selby MJ; Chien D; O'Hagan DT; Houghton M; Paliard X
    J Immunol; 2001 Mar; 166(5):3589-98. PubMed ID: 11207320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms.
    Opal SM; Palardy JE; Chen WH; Parejo NA; Bhattacharjee AK; Cross AS
    J Infect Dis; 2005 Dec; 192(12):2074-80. PubMed ID: 16288370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of nasal clearance of nontypeable Haemophilus influenzae by oral immunization with outer membrane proteins.
    Suzuki M; Kurono Y; Kodama S; Shigemi H; Mogi G
    Acta Otolaryngol; 1998 Nov; 118(6):864-9. PubMed ID: 9870635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status and potential application of ISCOMs in veterinary medicine.
    Morein B; Hu KF; Abusugra I
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.
    Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P
    Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcutaneous immunization with an outer membrane protein of Porphyromonas gingivalis without adjuvant elicits marked antibody responses.
    Koizumi Y; Kurita-Ochiai T; Yamamoto M
    Oral Microbiol Immunol; 2008 Apr; 23(2):131-8. PubMed ID: 18279181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
    Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions.
    Ekström J; Hu KF; Bengtsson KL; Morein B
    Vaccine; 1999 Jun; 17(20-21):2690-701. PubMed ID: 10418920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action.
    Grdic D; Smith R; Donachie A; Kjerrulf M; Hörnquist E; Mowat A; Lycke N
    Eur J Immunol; 1999 Jun; 29(6):1774-84. PubMed ID: 10382739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination.
    Bal SM; Hortensius S; Ding Z; Jiskoot W; Bouwstra JA
    Vaccine; 2011 Jan; 29(5):1045-52. PubMed ID: 21129393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis.
    Maeba S; Otake S; Namikoshi J; Shibata Y; Hayakawa M; Abiko Y; Yamamoto M
    Vaccine; 2005 Mar; 23(19):2513-21. PubMed ID: 15752838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae.
    Bandholtz L; Kreuger MR; Svanholm C; Wigzell H; Rottenberg ME
    Clin Exp Immunol; 2002 Dec; 130(3):393-403. PubMed ID: 12452828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.